Jong Han Yu

2.2k total citations
61 papers, 1.5k citations indexed

About

Jong Han Yu is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Jong Han Yu has authored 61 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 37 papers in Cancer Research and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Jong Han Yu's work include Breast Cancer Treatment Studies (28 papers), HER2/EGFR in Cancer Research (11 papers) and Breast Lesions and Carcinomas (10 papers). Jong Han Yu is often cited by papers focused on Breast Cancer Treatment Studies (28 papers), HER2/EGFR in Cancer Research (11 papers) and Breast Lesions and Carcinomas (10 papers). Jong Han Yu collaborates with scholars based in South Korea, United States and Ethiopia. Jong Han Yu's co-authors include Gyungyub Gong, Hee Jin Lee, In Ah Park, In Hye Song, Joo Young Kim, Sei Hyun Ahn, Jong Won Lee, Byung Ho Son, Christopher W. Wong and Abu B. Al‐Mehdi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Jong Han Yu

54 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jong Han Yu South Korea 22 859 576 499 274 265 61 1.5k
Eugen Ruckhaeberle Germany 15 863 1.0× 705 1.2× 348 0.7× 229 0.8× 211 0.8× 20 1.5k
Susan Fineberg United States 22 636 0.7× 494 0.9× 454 0.9× 146 0.5× 302 1.1× 61 1.6k
Cristiano Ferrario Canada 18 1.3k 1.5× 653 1.1× 476 1.0× 275 1.0× 253 1.0× 81 1.9k
Yoshiya Horimoto Japan 20 694 0.8× 378 0.7× 495 1.0× 170 0.6× 154 0.6× 97 1.2k
Jieqiong Liu China 23 801 0.9× 543 0.9× 504 1.0× 172 0.6× 232 0.9× 73 1.6k
Angela Espósito Italy 21 1.1k 1.3× 762 1.3× 404 0.8× 153 0.6× 148 0.6× 56 1.6k
Sergio Aguggini Italy 17 665 0.8× 709 1.2× 470 0.9× 116 0.4× 140 0.5× 34 1.3k
Maria Martinez‐García Spain 18 675 0.8× 318 0.6× 386 0.8× 189 0.7× 160 0.6× 81 1.3k
Laura Pizzuti Italy 23 906 1.1× 410 0.7× 454 0.9× 206 0.8× 140 0.5× 96 1.7k
Sandra A. O’Toole Australia 16 861 1.0× 497 0.9× 467 0.9× 132 0.5× 196 0.7× 29 1.4k

Countries citing papers authored by Jong Han Yu

Since Specialization
Citations

This map shows the geographic impact of Jong Han Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jong Han Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jong Han Yu more than expected).

Fields of papers citing papers by Jong Han Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jong Han Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jong Han Yu. The network helps show where Jong Han Yu may publish in the future.

Co-authorship network of co-authors of Jong Han Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jong Han Yu. A scholar is included among the top collaborators of Jong Han Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jong Han Yu. Jong Han Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Seok Won, Jong Han Yu, Se Kyung Lee, et al.. (2025). Real-world evidence of the efficacy of neoadjuvant pembrolizumab in triple-negative breast cancer: A surgeon's point of view. European Journal of Surgical Oncology. 51(8). 110011–110011.
2.
Ahn, Sung Gwe, Jong Han Yu, Yeon Jin Kim, et al.. (2025). Additional prognostic value of the BCT score in ER+HER2- breast cancer patients receiving a 21-gene assay-guided adjuvant treatments. Frontiers in Oncology. 15. 1517073–1517073.
3.
Nam, Seok Jin, Seok Won Kim, Joon Jeong, et al.. (2024). The Prognostic Impact of HER2-Low and Menopausal Status in Triple-Negative Breast Cancer. Cancers. 16(14). 2566–2566. 4 indexed citations
4.
Perrin, Jessica, Frank Wippich, Jeremy D. Waight, et al.. (2023). Abstract 6647: Dostarlimab shows dose-dependent immune activation of the tumor microenvironment in a patient-derived NSCLC explant model similar to pembrolizumab. Cancer Research. 83(7_Supplement). 6647–6647.
5.
Park, Yeon Hee, Vassiliki Karantza, Seri Park, et al.. (2021). Prevalence, treatment patterns, and prognosis of low estrogen receptor-positive (1% to 10%) breast cancer: a single institution’s experience in Korea. Breast Cancer Research and Treatment. 189(3). 653–663. 10 indexed citations
6.
Kim, Isaac, Sung Wook Seo, Jeong Eon Lee, et al.. (2019). Deep Survival Model Identifies Prognostic Subgroups of Triple-Negative Breast Cancer Patients. 4(1). 1 indexed citations
7.
8.
Lee, Sae Byul, Jong Han Yu, Hee Jeong Kim, et al.. (2018). Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer with axillary node metastasis: A survey of clinical practice. Asian Journal of Surgery. 42(1). 314–319. 4 indexed citations
9.
Kim, Ji‐Yeon, Ji Eun Lim, Hae Hyun Jung, et al.. (2018). Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort. Breast Cancer Research and Treatment. 171(3). 737–745. 27 indexed citations
10.
Lee, Soo‐Jeong, Sung Ho Choi, Sei Hyun Ahn, et al.. (2017). Evaluation of a novel approach to circulating tumor cell isolation for cancer gene panel analysis in patients with breast cancer. Oncology Letters. 13(5). 3025–3031. 8 indexed citations
11.
Kim, Ji‐Yeon, Jong Han Yu, Seok Jin Nam, et al.. (2017). Genetic and Clinical Characteristics of Phyllodes Tumors of the Breast. Translational Oncology. 11(1). 18–23. 28 indexed citations
12.
Lee, Hee Jin, In Ah Park, In Hye Song, et al.. (2015). Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer. Journal of Clinical Pathology. 69(5). 422–430. 132 indexed citations
13.
Lee, Hee Jin, Joo Young Kim, In Ah Park, et al.. (2015). Prognostic Significance of Tumor-Infiltrating Lymphocytes and the Tertiary Lymphoid Structures in HER2-Positive Breast Cancer Treated With Adjuvant Trastuzumab. American Journal of Clinical Pathology. 144(2). 278–288. 102 indexed citations
14.
Lee, Hee Jin, Joo Young Kim, In Hye Song, et al.. (2015). High mobility group B1 and N1 (HMGB1 and HMGN1) are associated with tumor-infiltrating lymphocytes in HER2-positive breast cancers. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 467(6). 701–709. 25 indexed citations
15.
Lim, Seung Taek, Jong Han Yu, Heung Kyu Park, et al.. (2014). A comparison of the clinical outcomes of patients with invasive lobular carcinoma and invasive ductal carcinoma of the breast according to molecular subtype in a Korean population. World Journal of Surgical Oncology. 12(1). 56–56. 21 indexed citations
16.
Lee, Hee Jin, An Na Seo, So Yeon Park, et al.. (2014). Low Prognostic Implication of Fibroblast Growth Factor Family Activation in Triple-negative Breast Cancer Subsets. Annals of Surgical Oncology. 21(5). 1561–1568. 52 indexed citations
17.
Kim, Sinae, Je‐Keun Rhee, Hyun Ju Yoo, et al.. (2014). Bioinformatic and metabolomic analysis reveals miR-155 regulates thiamine level in breast cancer. Cancer Letters. 357(2). 488–497. 41 indexed citations
18.
Lee, Sae Byul, Jong Won Lee, Jong Han Yu, et al.. (2014). Preoperative serum HER2 extracellular domain levels in primary invasive breast cancer. BMC Cancer. 14(1). 929–929. 13 indexed citations
19.
Lee, Hyo Sang, Beom Seok Ko, Sei Hyun Ahn, et al.. (2014). Diagnostic performance of breast-specific gamma imaging in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Research and Treatment. 145(1). 91–100. 22 indexed citations
20.
Kim, Hee Jeong, Jong Won Lee, Jong Han Yu, et al.. (2010). Vitamin D Deficiency is Correlated with Poor Outcomes in Patients with Luminal-type Breast Cancer. Annals of Surgical Oncology. 18(7). 1830–1836. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eugen Ruckhaeberle Breakdown of academic impact, for papers by Susan Fineberg Breakdown of academic impact, for papers by Cristiano Ferrario Breakdown of academic impact, for papers by Yoshiya Horimoto Breakdown of academic impact, for papers by Jieqiong Liu Breakdown of academic impact, for papers by Angela Espósito Breakdown of academic impact, for papers by Sergio Aguggini Breakdown of academic impact, for papers by Maria Martinez‐García Breakdown of academic impact, for papers by Laura Pizzuti Breakdown of academic impact, for papers by Sandra A. O’Toole
Rankless by CCL
2026